CrushSCI.com
99.3Average days
87.5Median days
42Fastest days
272Longest days
1842025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

56 days

Real-world treatment patterns and survival in advanced/metastatic triple-negative breast cancer in Japan

Authors
Hitomi Sanno; Yuichiro Ito; Kazuko Taniguchi; Yuya Yoshimoto; Shigehira SajiShow moreShow less
Affiliations
1. MSD K.K; 2. Fukushima Medical UniversityShow moreShow less
Source PDF DOI Publisher page
95 days

LUMINATE-101-Maccabi: a real-world study of treatment patterns and clinical outcomes in patients with non-squamous metastatic non-small cell lung cancer in an Israeli Health Maintenance Organization (HMO)

Authors
Sarah Sharman Moser; Alona Zer; Andre Hejazi; Netta Passwell; Moshe Hoshen; Amin Virani; Simon Sharmokh; Nathalie Daaboul; Sivan Gazit; Jair BarShow moreShow less
Affiliations
1. Maccabi Healthcare Services; 2. Rambam Health Care Campus, Technion Israel Technology Institutes; 3. AbbVie Inc; 4. Université de Sherbrooke Canada; 5. Sheba Medical Center; 6. Tel Aviv UniversityShow moreShow less
Source PDF DOI Publisher page
85 days

Expert consensus on the role of immunotherapy in nasopharyngeal carcinoma: clinical and economic perspectives from the GCC region

Authors
Anas Hamad; Ahmed El-Sheashaey; Ahmed S. Alanazi; Fahmeeda Khan; Mansoor Ahmed Khan; Mohammed Alfar; Osama Abu Tabar; Rana Aljaber; Shereen ElazzazyShow moreShow less
Affiliations
1. Hamad Medical Corporation; 2. Qatar University; 3. Kuwait Cancer Control Center (KCCC); 4. King Fahad Medical City; 5. RMS Hospitals; 6. King Abdulaziz Medical City; 7. Burjeel Cancer Institute; 8. Cleveland Clinic Abu Dhabi; 9. Case Western Reserve University; 10. University Medical City (UMC); 11. National University of Science and TechnologyShow moreShow less
Source PDF DOI Publisher page
141 days

Complications following small-molecule inhibitors for non-small cell lung cancer

Authors
Caroline Kamali; Simon EkmanShow moreShow less
Affiliations
1. Karolinska Institutet; 2. Karolinska University HospitalShow moreShow less
Source PDF DOI Publisher page
84 days

Artificial intelligence in retinoblastoma and uveal melanoma - a narrative review

Authors
Bharat Gurnani; Kirandeep KaurShow moreShow less
Affiliations
1. Gomabai NetralayaShow moreShow less
Source PDF DOI Publisher page
272 days

Quantitative and qualitative fecal immunochemical tests for colorectal cancer screening in Kazakhstan: a comparative study

Authors
Abay Jumanov; Dilyara Kaidarova; Alma Zhylkaidarova; Innara Turkpenova; Ainash Oshibayeva; Yernar MyrzakulovShow moreShow less
Affiliations
1. Kazakh Institute of Oncology and Radiology; 2. Khoja Akhmet Yassawi International Kazakh-Turkish University; 3. Tengri LLPShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.